IFNG and systemic lupus erythematosus: Treatment of splenocytes from C57Bl/6 or lupus-prone NZB/W mice and murine cell lines with either IFN-α or IFN-γ led to increased expression of ERα mRNA and protein levels, via transcriptional activation of the Esr1 promoter through STAT1.